Tenax Therapeutics, Inc. (TENX) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TENX Revenue Growth
Revenue Breakdown (FY 2013)
TENX's revenue distribution by segment and geography for fiscal year 2013
By Product/Segment
By Geography
TENX Revenue Analysis (2013–2024)
As of May 8, 2026, Tenax Therapeutics, Inc. (TENX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, TENX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $288,726 in 2013.
Revenue diversification analysis shows TENX's business is primarily driven by United States (100%). With over half of revenue concentrated in United States, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), ACAD (+9.9% YoY), and PRTA (-58.0% YoY). Compare TENX vs NKTR →
TENX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TENXCurrent | $0 | - | - | - | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% |
TENX Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-19,494,000 | - |
| 2023 | $0 | - | $0 | - | $-8,234,000 | - |
| 2022 | $0 | - | $0 | - | $-11,052,643 | - |
| 2021 | $0 | - | $0 | - | $-32,728,241 | - |
| 2020 | $0 | - | $-114,748 | - | $-9,867,930 | - |
| 2019 | $0 | - | $0 | - | $-8,555,264 | - |
| 2018 | $0 | - | $-9,015 | - | $-6,893,280 | - |
| 2017 | $0 | - | $-13,621 | - | $-9,205,898 | - |
| 2016 | $0 | -100.0% | $-18,952 | - | $-52,650,739 | - |
| 2015 | $49K | +0.0% | $40K | 80.3% | $-15,638,247 | -31729.6% |
See TENX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TENX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TENX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTENX — Frequently Asked Questions
Quick answers to the most common questions about buying TENX stock.
Is TENX's revenue growth accelerating or slowing?
TENX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TENX's long-term revenue growth rate?
Tenax Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TENX's revenue distributed by segment?
TENX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.